BioReference Laboratories is a leading provider of diagnostic testing services in the United States. The company was founded in 1981 by Dr. Marc Grodman and is headquartered in Elmwood Park, New Jersey.

BioReference Laboratories offers a wide range of products and services including blood, urine, and tissue testing, as well as genetic testing and women's health diagnostics. The company operates a network of laboratories across the United States, equipped with state-of-the-art equipment and staffed by highly trained professionals. BioReference Laboratories is known for its advanced testing capabilities and commitment to accuracy and precision.

On a global scale, BioReference Laboratories operates as a subsidiary of OPKO Health, Inc., a diversified healthcare company. OPKO Health acquired BioReference Laboratories in 2015. This partnership has allowed BioReference Laboratories to expand its reach and offer its services to a larger customer base.

BioReference Laboratories has also established partnerships and collaborations with various organizations in the healthcare industry. For example, the company has partnered with Mount Sinai Health System to create the Mount Sinai-Quest Diagnostics partnership, which aims to advance precision medicine through large-scale genetic testing. In terms of market position, BioReference Laboratories is one of the largest diagnostic testing laboratories in the United States.

The company has a strong presence in the market and has gained recognition for its high-quality testing services. It competes with other major diagnostic laboratories such as Quest Diagnostics and LabCorp. While specific global sales figures are not readily available, BioReference Laboratories is considered a key player in the industry.

In recent years, BioReference Laboratories has undergone significant growth and expansion. The acquisition by OPKO Health has allowed the company to enhance its capabilities and expand its reach. The company has also made advancements in the field of genetic testing, introducing innovative tests to improve patient care and treatment outcomes.

These changes have positioned BioReference Laboratories for continued growth and success in the field of diagnostic testing. As of the latest available information, BioReference Laboratories continues to provide reliable diagnostic testing services across the United States. The company remains committed to its mission of delivering high-quality testing solutions to healthcare providers and patients alike